Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (3,981,144) $ (1,847,406)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment of goodwill 2,524,034
Gain on forgiveness of PPP loan (279,191)
Impairment of inventory 156,600
Stock-based compensation 361,363 1,141,932
Bad debt expense 48,000 78,125
Changes in operating assets and liabilities:    
Accounts receivable (16,780) 50,693
Prepaid expenses and other assets 25,647 (31,238)
Accounts payable and accrued liabilities 433,966 83,366
Deferred revenue (201,250) 107,083
Net cash provided by (used in) operating activities (806,164) (540,036)
Cash flows from investing activities:    
Proceeds from potential acquisition 165,000
Net cash provided by investing activities 165,000
Cash flows from financing activities:    
Proceeds from the sale of common stock 572,906 725,050
Payments of loans payable (57,390) (6,627)
Payments of stockholder advance (32,378)
Proceeds from advances - related party 193,558
Payments of advances - related party (193,558)
Net cash provided by financing activities 483,138 718,423
Net (decrease) increase in cash (158,026) 178,387
Cash, beginning of period 249,462 71,075
Cash, end of period 91,436 249,462
Supplemental disclosures of cash flow information:    
Cash paid for interest 6,448 131
Cash paid for income taxes
Non-cash investing and financing activities:    
Commitment shares issued in conjunction with capital raise 200,000
Shares issued for vested restricted stock units 17 7
Shares issued for settlement of class action 600,000
Shares issued for cashless exercise of warrants $ 15